The FMHR traders reveal their final trades.
A DC Federal Judge dismissed investor lawsuits related to Fannie Mae and Freddie Mac profits. CNBC's Kate Kelly says the ruling is a major potential blow to smart money involved.
Some investors are warning a wave of auto loan defaults could lay ahead, reports CNBC's Kate Kelly.
Crude is coming off its worst quarter in 2 years. Dan Dicker of MercBloc, sees oil price getting to a much higher price over the next two years to at least $125.
CNBC's Jane Wells asked Wynn Resorts Chairman and CEO Steve Wynn, what will happen with the unfinished Fontainebleau casino resort on the Las Vegas Strip.
FMHR trader Jon Najarian explains why he is still short shares of Apple.
A close look at what's bringing the markets lower, with professional day trader Larry Altman of CBD Trading, and Rob Sechan of UBS.
CNBC's Kate Rogers reports Coca-Cola Enterprises is scaling back its executive equity compensation plan, and on David Winters of Wintergreen Advisers' comments.
Rob Sechan of UBS, shares his fourth quarter playbook.
Dissecting the current market environment for the first trading day of the new quarter, with the FMHR traders.
The Fast Money traders share their final trades of the day and what they're looking out for on Wednesday.
Shares of Angie's List spike after hours following an FT report the company has hired bankers and may consider a sale, reports Dominic Chu.
CNBC's Meg Tirrell provides insight to comments by the CDC director about the first confirmed Ebola case in the U.S.
David L. Lakey, M.D., Commissioner of the Texas Department of State Health Services, discusses the handling of the patient with Ebola.
CDC Director Dr. Tom Frieden explains the CDC's investment to ensuring the spread of Ebola is stopped.
Your best plays for October, with Paul Hickey, Bespoke Investment Group.
CNBC's Melissa Lee reports pharmaceutical companies with potential Ebola treatments are on the move after hours, as well as airline stocks.
CDC Director Dr. Tom Frieden provides insight to the spread of Ebola, and announces an individual traveling from Liberia to the United States has been diagnosed with Ebola in Texas.
Sarepta President and CEO Chris Garabedian says his company has enough clinical trial quality drug on hand to treat a couple dozen Ebola patients if requested.
CNBC's Meg Tirrell reports Texas health officials have confirmed the Ebola patient is in Texas, and had a recent history of travel to West Africa.